These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8617147

  • 21. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
    Fornaciari G, Maccari S, Borgatti PP, Rustichelli R, Amelio N, Lattuada I, Plancher AC.
    J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349
    [Abstract] [Full Text] [Related]

  • 22. ACUTE MYOPERICARDITIS IN A PATIENT WITH ULCERATIVE COLITIS AND THE ROLE OF MESALAMINE: A CASE REPORT.
    Papaefthymiou A, Kyriakos N, Giakoumis M, Doulberis M, Mylonas I, Kountouras J, Liatsos C.
    Gastroenterol Nurs; 1997 Jan; 45(4):276-277. PubMed ID: 35283437
    [No Abstract] [Full Text] [Related]

  • 23. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M, Rascarachi G, Díez Rodríguez R, Arias Rodríguez L, Del Pozo Maroto E, Muñoz Núñez F.
    Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
    [No Abstract] [Full Text] [Related]

  • 24. Lung and skin hypersensitivity to 5-aminosalicylic acid.
    le Gros V, Saveuse H, Lesur G, Brion N.
    BMJ; 1991 Apr 20; 302(6782):970. PubMed ID: 1827746
    [No Abstract] [Full Text] [Related]

  • 25. 5-Aminosalicylic acid, 1,000-mg caplets versus 500-mg tablets, in maintenance of remission in ulcerative colitis.
    Odes HS.
    J Clin Gastroenterol; 1997 Jun 20; 24(4):287-8. PubMed ID: 9252863
    [No Abstract] [Full Text] [Related]

  • 26. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
    Ann Intern Med; 1996 Jan 15; 124(2):204-11. PubMed ID: 8533995
    [Abstract] [Full Text] [Related]

  • 27. [5-aminosalicylic acid and chronic inflammatory bowel diseases in children].
    Klotz U.
    Klin Padiatr; 1995 Jan 15; 207(5):285-7. PubMed ID: 7500605
    [Abstract] [Full Text] [Related]

  • 28. Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis.
    Ishikawa N, Imamura T, Nakajima K, Yamaga J, Yuchi H, Ootsuka M, Inatsu H, Aoki T, Eto T.
    Intern Med; 2001 Sep 15; 40(9):901-4. PubMed ID: 11579953
    [Abstract] [Full Text] [Related]

  • 29. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ, Mayer L, Abreu MT.
    J Clin Gastroenterol; 2011 Jan 15; 45(1):83-4. PubMed ID: 20535023
    [No Abstract] [Full Text] [Related]

  • 30. Mesalazine-induced myopericarditis in a patient with ulcerative colitis.
    Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H.
    Int J Colorectal Dis; 2006 Mar 15; 21(2):199-200. PubMed ID: 15726390
    [No Abstract] [Full Text] [Related]

  • 31. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.
    Stelts S, Taylor MH, Nappi J, Van Bakel AB.
    Ann Pharmacother; 2008 Jun 15; 42(6):904-5. PubMed ID: 18430794
    [No Abstract] [Full Text] [Related]

  • 32. New desensitization regimen with mesalamine granules in a patient with ulcerative colitis and mesalamine intolerance.
    Oustamanolakis P, Koutroubakis IE.
    Inflamm Bowel Dis; 2011 Feb 15; 17(2):E8-9. PubMed ID: 20848496
    [No Abstract] [Full Text] [Related]

  • 33. [False melanuria in a female patient treated with 5-ASA for ulcerative colitis].
    Cuende JI, Gómez MT, García M, Pérez IJ.
    Med Clin (Barc); 1995 May 27; 104(20):798. PubMed ID: 7783478
    [No Abstract] [Full Text] [Related]

  • 34. Adverse pulmonary effects of mesalamine.
    Muzzi A, Ciani F, Bianchini D, Festini G, Volpe C.
    Chest; 1995 Oct 27; 108(4):1181. PubMed ID: 7555145
    [No Abstract] [Full Text] [Related]

  • 35. [Myopericarditis in a patient with ulcerative colitis treated with mesalazine].
    Martín M, Santamarta E, de la Iglesia JM, Saiz A.
    Med Clin (Barc); 2010 Jan 23; 134(1):43-4. PubMed ID: 19423137
    [No Abstract] [Full Text] [Related]

  • 36. [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].
    Machida H, Shinohara T, Hatakeyama N, Inayama M, Hosokawa E, Ogushi F.
    Nihon Kokyuki Gakkai Zasshi; 2011 Jul 23; 49(7):538-42. PubMed ID: 21842693
    [Abstract] [Full Text] [Related]

  • 37. Mesalamine hypersensitivity and Kounis syndrome in a pediatric ulcerative colitis patient.
    Kounis GN, Kouni SA, Hahalis G, Kounis NG.
    World J Gastroenterol; 2008 Dec 14; 14(46):7141-2. PubMed ID: 19084925
    [Abstract] [Full Text] [Related]

  • 38. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L, Cohen H, Dooley C, Rubin P, Orchard J.
    Am J Gastroenterol; 1996 Jul 14; 91(7):1338-42. PubMed ID: 8677990
    [Abstract] [Full Text] [Related]

  • 39. Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine.
    Tzivras M, Konstandinidis A, Hatzis G, Paraskeva K, Skandalis N, Archimandritis A.
    Eur J Gastroenterol Hepatol; 1997 Jul 14; 9(7):729-30. PubMed ID: 9262986
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of ulcerative colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.
    Johnson LK, Pruitt RE, Green JR.
    Am J Gastroenterol; 2003 Jan 14; 98(1):216-9. PubMed ID: 12526969
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.